In May 2022, alarming headlines emerged: A mysterious and deadly disease was spreading in Central Africa. Was this the beginning of a new pandemic? Today, we know that it was Mpox (formerly known as monkeypox), a viral...
Today, the Citizen Science project CiFly will enter its second year. This year, 9th and 10th grade students from the Alexander-von-Humboldt-Gymnasium will again have the opportunity to get to know the Helmholtz...
Infectious keratitis blinds 1.5 million people worldwide every year. This severe eye disease is often caused by the hospital germ Pseudomonas aeruginosa, which the World Health Organization considers one of the most...
The CRISPR-Cas gene scissors offer a wide range of potential applications, from the treatment of genetic diseases to antiviral therapies and diagnostics. However, to safely harness their powers, scientists are searching...
Construction of a modern new building for the Helmholtz Institute for One Health (HIOH) will begin this year on the University of Greifswald's Berthold-Beitz-Platz campus. Founded in 2021 as a site of the Helmholtz...
The Republic of Côte d'Ivoire is a vibrant country in West Africa with rich cultural traditions and diverse ecosystems. Despite its beauty and vitality, the country faces significant challenges in its health system,...
The only natural host of the hepatitis C virus (HCV) is humans. Model organisms for laboratory studies, especially mice, cannot be infected which makes the search for a vaccine against HCV extremely difficult because...
Viruses are masters at disguise. When they are pushed too far by our immune system, they send new virus variants into play that are no longer recognized by immune cells. They escape our immune system by mutating the...
The European Research Council (ERC) has announced the results of the latest round of its “Proof of Concept Grant” 2024 competition. Among the researchers selected for funding is Prof. Yang Li, co-director of the Centre...